Submit Deal

SURMODICS

Summary

Surmodics is a provider of surface modification technologies for intravascular medical devices and a provider of chemical components for in vitro diagnostic (IVD) immunoassay tests and microarrays.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 491 M

Avg. Deal Size£ 491 M

Market Context

Senior Management

Gary Maharaj
President and CEO
Jack Powell
Senior Vice President

Sort

white & case

HQ - New York

legal advisors to financial advisors (1)

1 Shared Deal

1 For

£ 491 M

Total Value

jefferies & company

HQ - New York

financial advisors (1)

1 Shared Deal

1 For

£ 491 M

Total Value

faegre drinker biddle & reath

HQ - Philadelphia, Philadelphia, Pennsylvania

legal advisors (1)

1 Shared Deal

1 For

£ 491 M

Total Value

kirkland & ellis

HQ - Chicago, United States

legal advisors (1)

1 Shared Deal

1 Opposite

£ 491 M

Total Value

cleary gottlieb steen & hamilton

HQ - New York

legal advisors (1)

1 Shared Deal

1 Opposite

£ 491 M

Total Value

goldman sachs

HQ - New York

financial advisors (1)

1 Shared Deal

1 Opposite

£ 491 M

Total Value

oak hill advisors

HQ - New York

debt providers (1)

1 Shared Deal

1 Opposite

£ 491 M

Total Value

latham & watkins

HQ - New York, United States

legal advisors to debt providers (1)

1 Shared Deal

1 Opposite

£ 491 M

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy